Abbott Laboratories
ABT
#93
Rank
NZ$311.44 B
Marketcap
NZ$179.23
Share price
0.67%
Change (1 day)
-22.09%
Change (1 year)
Categories

Abbott Laboratories (ABT), (founding name: Abbott Alkaloid Company) is a global pharmaceutical company with around 73,000 employees in 150 countries. Abbott was founded in 1888 by Wallace C. Abbott (1857-1921) and is headquartered in Abbott Park, a northern suburb of Chicago, Illinois.

EPS for Abbott Laboratories (ABT)

EPS in 2025 (TTM): NZ$6.42

According to Abbott Laboratories's latest financial reports the company's current EPS (TTM) is NZ$6.50. In 2024 the company made an earnings per share (EPS) of NZ$13.41 an increase over its 2023 EPS that were of NZ$5.72.

EPS history for Abbott Laboratories from 2013 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$6.42-52.15%
2024NZ$13.41134.51%
2023NZ$5.72-23.23%
2022NZ$7.457.5%
2021NZ$6.9357.41%
2020NZ$4.4021.54%
2019NZ$3.6254.75%
2018NZ$2.34389.07%
2017NZ$0.48-71.01%
2016NZ$1.65-68.01%
2015NZ$5.1696.13%
2014NZ$2.63-8.64%
2013NZ$2.88

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$19.32 197.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.49 91.99%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.36-63.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$6.23-4.27%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Thermo Fisher Scientific
TMO
NZ$30.81 373.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
NZ$3.40-47.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
NZ$4.21-35.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$6.00-7.74%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$10.28 58.12%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$6.53 0.47%๐Ÿ‡ฌ๐Ÿ‡ง UK